Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Papers (229)
- Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, et al. Radiation-induced xerostomia and cariogenic dietary habits. Supportive Care in Cancer. 2024. 32. 2
- Kurato Miyazaki, Atsushi Nakayama, Motoki Sasaki, Daisuke Minezaki, Kohei Morioka, Kentaro Iwata, Teppei Masunaga, Yoko Kubosawa, Mari Mizutani, Yukie Hayashi, et al. Resectability of Small Duodenal Tumors: A Randomized Controlled Trial Comparing Underwater Endoscopic Mucosal Resection and Cold Snare Polypectomy. The American journal of gastroenterology. 2023
- Hiroya Taniguchi, Kentaro Yamazaki, Toshiki Masuishi, Takeshi Kawakami, Yusuke Onozawa, Kazunori Honda, Shigenori Kadowaki, Yukiya Narita, Takahiro Tsushima, Satoshi Hamauchi, et al. Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study. The oncologist. 2023. 28. 11. e1108-e1113
- Tetsuhiko Asao, Takehito Shukuya, Tomoyasu Mimori, Yasushi Goto, Hiroshi Tanaka, Koichi Takayama, Yukari Tsubata, Motoko Tachihara, Takuji Suzuki, Kyoichi Kaira, et al. Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101). Clinical lung cancer. 2023. 24. 7. e247-e253
- Kazushige Wakuda, Hirotsugu Kenmotsu, Yuki Sato, Atsushi Nakamura, Hiroaki Akamatsu, Motoko Tachihara, Satoru Miura, Toshihide Yokoyama, Keita Mori, Kazuhiko Nakagawa, et al. Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L). BMC cancer. 2023. 23. 1. 902-902
- Naomi Fukuzaki, Yoshimi Kiyozumi, Satomi Higashigawa, Yasue Horiuchi, Hiroyuki Matsubayashi, Seiichiro Nishimura, Keita Mori, Akifumi Notsu, Izumi Suishu, Sumiko Ohnami, et al. A Cross-sectional Study of Regret in Cancer Patients After Sharing Test Results for Pathogenic Germline Variants of Hereditary Cancers With Relatives. Cancer nursing. 2023
- Kyoichi Kaira, Ou Yamaguchi, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Shin Yanagisawa, Norimitsu Kasahara, Tetsuya Higuchi, et al. Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer. Cancer imaging : the official publication of the International Cancer Imaging Society. 2023. 23. 1. 23-23
- Atsushi Nakamura, Ou Yamaguchi, Keita Mori, Keita Miura, Motohiro Tamiya, Tomohiro Oba, Noriko Yanagitani, Hideaki Mizutani, Takashi Ninomiya, Tomosue Kajiwara, et al. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study). European journal of cancer (Oxford, England : 1990). 2023. 184. 62-72
- Takuya Fukushima, Tetsuya Tsuji, Jiro Nakano, Shun Ishii, Shinsuke Sugihara, Hiroshi Sato, Juichi Kawakami, Hitoshi Kagaya, Akira Tanuma, Ryuichi Sekine, et al. がん診療連携拠点病院における入院がんリハビリテーション治療の詳細. Palliative Care Research. 2023. 18. 2. 143-152
- Osamu Dohi, Shoko Ono, Kenro Kawada, Shinji Kitamura, Waku Hatta, Shinichiro Hori, Hiromitsu Kanzaki, Takahisa Murao, Nobuaki Yagi, Fumisato Sasaki, et al. Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms. Journal of gastroenterology and hepatology. 2023. 38. 1. 79-86
- 大森 翔太, 野津 昭文, 盛 啓太, 釼持 広知, 豆鞘 伸昭, 小林 玄機, 高 遼, 和久田 一茂, 小野 哲, 内藤 立暁, et al. 進行肺癌患者における静脈血栓塞栓症の影響(多施設共同前向き観察研究VISUAL studyの肺癌患者の追加解析). 肺癌. 2022. 62. 6. 612-612
- 桐田 圭輔, 釼持 広知, 坂井 和子, 盛 啓太, 加藤 晃史, 菅原 俊一, 米嶋 康臣, 東 公一, 中川 和彦, 山本 信之, et al. 未治療EGFR陽性NSCLCに対するOsimertinib+BevacizumabとOsimertinibのランダム化第2相試験 WJOG9717L. 肺癌. 2022. 62. 6. 566-566
- Kosei Doshita, Yuya Tabuchi, Hirotsugu Kenmotsu, Shota Omori, Takanori Kawabata, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Yuko Iida, Nobuaki Mamesaya, et al. Incidence and treatment outcome of radiation pneumonitis in limited-stage small-cell lung cancer patients treated with concurrent accelerated hyperfractionated radiotherapy and chemotherapy. Advances in Radiation Oncology. 2022. 101129-101129
- Hirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori, Terufumi Kato, Shunichi Sugawara, Keisuke Kirita, Yasuto Yoneshima, Koichi Azuma, Kazumi Nishino, Shunsuke Teraoka, et al. Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2022. 17. 9. 1098-1108
- Taichi Miyawaki, Hirotsugu Kenmotsu, Kosei Doshita, Hiroaki Kodama, Naoya Nishioka, Yuko Iida, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, et al. Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer. Cancer medicine. 2022. 12. 2. 1451-1460
- Ou Yamaguchi, Kyoichi Kaira, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Kazunari Tateishi, Norimitsu Kasahara, Tetsuya Higuchi, et al. Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer. Scientific reports. 2022. 12. 1. 11832-11832
- Taichi Miyawaki, Tateaki Naito, Kosei Doshita, Hiroaki Kodama, Mikiko Mori, Naoya Nishioka, Yuko Iida, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, et al. Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer. Thoracic cancer. 2022. 13. 14. 2064-2074
- Hirotsugu Kenmotsu, Keita Mori, Risa Mizuno, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, et al. Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naive patients with extensive-stage small-cell lung cancer. Lung Cancer. 2022. 164
- Takuya Fukushima, Tetsuya Tsuji, Noriko Watanabe, Takuro Sakurai, Aiko Matsuoka, Kazuhiro Kojima, Sachiko Yahiro, Mami Oki, Yusuke Okita, Shota Yokota, et al. Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan: The Current State of Outpatient Setting and Coordination after Discharge. Progress in Rehabilitation Medicine. 2022. 7. n/a-n/a
- Ken Haruma, Mototsugu Kato, Kenro Kawada, Takahisa Murao, Shoko Ono, Mitsuhiko Suehiro, Shinichiro Hori, Fumisato Sasaki, Tomoyuki Koike, Shinji Kitamura, et al. Diagnostic ability of linked color imaging in ultraslim endoscopy to identify neoplastic lesions in the upper gastrointestinal tract. Endoscopy international open. 2022. 10. 1. E88-E95
Return to Previous Page
